메뉴 건너뛰기




Volumn 26, Issue 6, 2006, Pages 680-687

Treatment and prognostic factors in patients with hepatocellular carcinoma

Author keywords

Cirrhosis; Hepatocellular carcinoma; Okuda and CLIP staging; Prognosis; Treatment modalities

Indexed keywords

ALBUMIN; ALCOHOL; ALPHA FETOPROTEIN; BILIRUBIN; TAMOXIFEN;

EID: 33745684425     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.001285.x     Document Type: Article
Times cited : (49)

References (37)
  • 1
    • 0035888074 scopus 로고    scopus 로고
    • Estimating the world cancer burden: GLOBOCAN 2000
    • Parkin D M, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001; 94: 153-6.
    • (2001) Int J Cancer , vol.94 , pp. 153-156
    • Parkin, D.M.1    Bray, F.2    Ferlay, J.3    Pisani, P.4
  • 2
    • 0035467993 scopus 로고    scopus 로고
    • Global cancer statistics in the year 2000
    • Parkin D M. Global cancer statistics in the year 2000. Lancet Oncol 2000; 2: 533-43.
    • (2000) Lancet Oncol , vol.2 , pp. 533-543
    • Parkin, D.M.1
  • 3
    • 0345041194 scopus 로고    scopus 로고
    • Risk groups and preventive strategies
    • Berr F, Bruix J, Hauss J, Wands J, Wittekind Ch, eds. Dordrecht: Kluwer Academic Publishers BV and Falk Foundation
    • Colombo M. Risk groups and preventive strategies. In: Berr F, Bruix J, Hauss J, Wands J, Wittekind Ch, eds. Malignant Liver Tumors. Basic Concepts and Clinical Management. Dordrecht: Kluwer Academic Publishers BV and Falk Foundation, 2003; 67-74.
    • (2003) Malignant Liver Tumors. Basic Concepts and Clinical Management , pp. 67-74
    • Colombo, M.1
  • 4
    • 0141491273 scopus 로고    scopus 로고
    • Hepatocellular carcinoma
    • Llovet J, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
    • (2003) Lancet , vol.362 , pp. 1907-1917
    • Llovet, J.1    Burroughs, A.2    Bruix, J.3
  • 5
    • 7044272630 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
    • Fattovich G, Strofollini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004; 127 (5 suppl 1): S35-S50.
    • (2004) Gastroenterology , vol.127 , Issue.SUPPL. 1
    • Fattovich, G.1    Strofollini, T.2    Zagni, I.3
  • 6
    • 0031041924 scopus 로고    scopus 로고
    • Morbidity and mortality in compensated cirrhosis type C: A retrospective follow up study of 384 patients
    • Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow up study of 384 patients. Gastroenterology 1997; 112: 463-72.
    • (1997) Gastroenterology , vol.112 , pp. 463-472
    • Fattovich, G.1    Giustina, G.2    Degos, F.3
  • 7
    • 0037369657 scopus 로고    scopus 로고
    • Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
    • Velásquez R, Rodríguez M, Navascués C, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003; 37: 520-7.
    • (2003) Hepatology , vol.37 , pp. 520-527
    • Velásquez, R.1    Rodríguez, M.2    Navascués, C.3
  • 8
    • 18144411666 scopus 로고    scopus 로고
    • Updated treatment approach to hepatocellular carcinoma
    • Llovet J. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40: 225-35.
    • (2005) J Gastroenterol , vol.40 , pp. 225-235
    • Llovet, J.1
  • 9
    • 14544302673 scopus 로고    scopus 로고
    • Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: Comparison of Okuda, CLIP and BCLC staging systems in a single Italian center
    • Grieco A, Pompili M, Caminiti G, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: Comparison of Okuda, CLIP and BCLC staging systems in a single Italian center. Gut 2005; 54: 411-8.
    • (2005) Gut , vol.54 , pp. 411-418
    • Grieco, A.1    Pompili, M.2    Caminiti, G.3
  • 10
    • 0021965806 scopus 로고
    • Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
    • Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985; 56: 918-28.
    • (1985) Cancer , vol.56 , pp. 918-928
    • Okuda, K.1    Ohtsuki, T.2    Obata, H.3
  • 11
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: The BCLC staging classification
    • Llovet J M, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Bru, C.2    Bruix, J.3
  • 12
    • 0031782818 scopus 로고    scopus 로고
    • A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
    • The Cancer of the Liver Italian Program (CLIP) investigators
    • The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998; 28: 751-5.
    • (1998) Hepatology , vol.28 , pp. 751-755
  • 13
    • 0034107047 scopus 로고    scopus 로고
    • Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma
    • The Cancer of the Liver Italian Program (CLIP) investigators
    • The Cancer of the Liver Italian Program (CLIP) investigators. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31: 840-5.
    • (2000) Hepatology , vol.31 , pp. 840-845
  • 14
    • 0032742183 scopus 로고    scopus 로고
    • Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
    • Llovet J, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999; 30: 1434-40.
    • (1999) Hepatology , vol.30 , pp. 1434-1440
    • Llovet, J.1    Fuster, J.2    Bruix, J.3
  • 15
    • 0345299824 scopus 로고    scopus 로고
    • Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
    • Mazaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
    • (1996) N Engl J Med , vol.334 , pp. 693-699
    • Mazaferro, V.1    Regalia, E.2    Doci, R.3
  • 16
    • 0038714350 scopus 로고    scopus 로고
    • Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection
    • Lencioni R, Allgaier H P, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-40.
    • (2003) Radiology , vol.228 , pp. 235-240
    • Lencioni, R.1    Allgaier, H.P.2    Cioni, D.3
  • 17
    • 9744265831 scopus 로고    scopus 로고
    • Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma
    • Sala M, Llovet J M, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-60.
    • (2004) Hepatology , vol.40 , pp. 1352-1360
    • Sala, M.1    Llovet, J.M.2    Vilana, R.3
  • 18
    • 7044260720 scopus 로고    scopus 로고
    • Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation
    • Omata M, Tateishi R, Yoshida H, et al. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127 (5 suppl 1): S159-S66.
    • (2004) Gastroenterology , vol.127 , Issue.5 SUPPL. 1
    • Omata, M.1    Tateishi, R.2    Yoshida, H.3
  • 19
    • 1242307267 scopus 로고    scopus 로고
    • Multimodal image-guide tailored therapy of early and intermediate hepatocellular carcinoma: Long-term survival in the experience of a single radiologic referral center
    • Livraghi T, Meloni F, Morabito A, et al. Multimodal image-guide tailored therapy of early and intermediate hepatocellular carcinoma: Long-term survival in the experience of a single radiologic referral center. Liver Transpl 2004; 10 (suppl 1): S98-S106.
    • (2004) Liver Transpl , vol.10 , Issue.SUPPL. 1
    • Livraghi, T.1    Meloni, F.2    Morabito, A.3
  • 20
    • 0037129704 scopus 로고    scopus 로고
    • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma
    • Llovet J, Real M, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. Lancet 2002; 359: 1734-39.
    • (2002) Lancet , vol.359 , pp. 1734-1739
    • Llovet, J.1    Real, M.2    Montana, X.3
  • 21
    • 0037308133 scopus 로고    scopus 로고
    • Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolisation improves survival
    • Llovet J, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolisation improves survival. Hepatology 2003; 37: 429-42.
    • (2003) Hepatology , vol.37 , pp. 429-442
    • Llovet, J.1    Bruix, J.2
  • 22
    • 0029127746 scopus 로고
    • Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients
    • Castells A, Bruix J, Bru C, et al. Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients. Gastroenterology 1995; 109: 917-22.
    • (1995) Gastroenterology , vol.109 , pp. 917-922
    • Castells, A.1    Bruix, J.2    Bru, C.3
  • 23
    • 15744397338 scopus 로고    scopus 로고
    • Use of tamoxifen in advanced-stage hepatocellular carcinoma: A systematic review
    • Nowak A, Stockler M, Pierce K, et al. Use of tamoxifen in advanced-stage hepatocellular carcinoma: A systematic review. Cancer 2005; 103: 1408-14.
    • (2005) Cancer , vol.103 , pp. 1408-1414
    • Nowak, A.1    Stockler, M.2    Pierce, K.3
  • 24
    • 0034856294 scopus 로고    scopus 로고
    • Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona -2000 EASL conference
    • Bruix J, Sherman M, Llovet J M, et al. Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona -2000 EASL conference. J Hepatol 2001; 35: 421-30.
    • (2001) J Hepatol , vol.35 , pp. 421-430
    • Bruix, J.1    Sherman, M.2    Llovet, J.M.3
  • 25
    • 0036786312 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Is current therapy really altering outcome?
    • Johnson P J. Hepatocellular carcinoma: Is current therapy really altering outcome? Gut 2002; 51: 459-62.
    • (2002) Gut , vol.51 , pp. 459-462
    • Johnson, P.J.1
  • 26
    • 14544273224 scopus 로고    scopus 로고
    • Predicting survival in early hepatocellular carcinoma
    • Ryder S. Predicting survival in early hepatocellular carcinoma. Gut 2005; 54: 328-9.
    • (2005) Gut , vol.54 , pp. 328-329
    • Ryder, S.1
  • 27
    • 16244369103 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in na American cohort
    • Marrero J A, Fontana R J, Barrat A, et al. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in na American cohort. Hepatology 2005; 41: 707-16.
    • (2005) Hepatology , vol.41 , pp. 707-716
    • Marrero, J.A.1    Fontana, R.J.2    Barrat, A.3
  • 28
    • 0034861620 scopus 로고    scopus 로고
    • Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 japanese patients
    • Ueno S, Tanable G, Sako K, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 japanese patients. Hepatology 2001; 34: 529-34.
    • (2001) Hepatology , vol.34 , pp. 529-534
    • Ueno, S.1    Tanable, G.2    Sako, K.3
  • 29
    • 28844435344 scopus 로고    scopus 로고
    • Treatment and outcomes of treating hepatocellular carcinoma among medicare recipients in the United States: A population-based study
    • in press
    • El-Serag H, Sieggel A, Davila G, et al. Treatment and outcomes of treating hepatocellular carcinoma among medicare recipients in the United States: A population-based study. J Hepatol in press.
    • J Hepatol
    • El-Serag, H.1    Sieggel, A.2    Davila, G.3
  • 30
    • 0030005110 scopus 로고    scopus 로고
    • Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management
    • Cedrone A, Rapaccini G L, Pompili M, et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver 1996; 16: 94-8.
    • (1996) Liver , vol.16 , pp. 94-98
    • Cedrone, A.1    Rapaccini, G.L.2    Pompili, M.3
  • 31
    • 0035397554 scopus 로고    scopus 로고
    • Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy
    • Pompili M, Rapaccini G L, Covino M, et al. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer 2001; 92: 126-35.
    • (2001) Cancer , vol.92 , pp. 126-135
    • Pompili, M.1    Rapaccini, G.L.2    Covino, M.3
  • 32
    • 0028871580 scopus 로고    scopus 로고
    • Treatment of small hepatocellular carcinoma with ethanol injection. Analysis of prognostic factors in 105 western patients
    • Lencioni R, Balthazar C, Caramella D, et al. Treatment of small hepatocellular carcinoma with ethanol injection. Analysis of prognostic factors in 105 western patients. Cancer 1996; 76: 1737-46.
    • (1996) Cancer , vol.76 , pp. 1737-1746
    • Lencioni, R.1    Balthazar, C.2    Caramella, D.3
  • 33
    • 9744265831 scopus 로고    scopus 로고
    • Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma
    • Sala M, Llovet J M, Viana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-60.
    • (2004) Hepatology , vol.40 , pp. 1352-1360
    • Sala, M.1    Llovet, J.M.2    Viana, R.3
  • 34
    • 28844464157 scopus 로고    scopus 로고
    • Characteristics at presentation and outcome of hepatocellular carcinoma in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)
    • in press
    • Pignata S. Characteristics at presentation and outcome of hepatocellular carcinoma in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). J Clin Gastroenterol; in press.
    • J Clin Gastroenterol
    • Pignata, S.1
  • 35
    • 0036085956 scopus 로고    scopus 로고
    • Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials
    • CammàC, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224: 47-54.
    • (2002) Radiology , vol.224 , pp. 47-54
    • Cammà, C.1    Schepis, F.2    Orlando, A.3
  • 36
    • 0028228435 scopus 로고
    • Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma
    • Martinez Cerezo F J, Tomas A, Donoso L, et al. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J Hepatol 1994; 20: 702-6.
    • (1994) J Hepatol , vol.20 , pp. 702-706
    • Martinez Cerezo, F.J.1    Tomas, A.2    Donoso, L.3
  • 37
    • 22344452017 scopus 로고    scopus 로고
    • Randomized controlled trail of tamoxifen in advanced hepatocellular carcinoma
    • Barbare J C, Bouche O, Bonnetain F, et al. Randomized controlled trail of tamoxifen in advanced hepatocellular carcinoma. J Clin Oncol 2005; 23: 4338-46.
    • (2005) J Clin Oncol , vol.23 , pp. 4338-4346
    • Barbare, J.C.1    Bouche, O.2    Bonnetain, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.